263 related articles for article (PubMed ID: 5283939)
1. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
Van Vunakis H; Farrow JT; Gjika HB; Levine L
Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
[TBL] [Abstract][Full Text] [Related]
2. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
CURTIS DR
Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
[No Abstract] [Full Text] [Related]
3. Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.
Fischer R; Goldman H
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):176-84. PubMed ID: 1233520
[TBL] [Abstract][Full Text] [Related]
4. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
Boess FG; Monsma FJ; Meyer V; Zwingelstein C; Sleight AJ
Mol Pharmacol; 1997 Sep; 52(3):515-23. PubMed ID: 9284367
[TBL] [Abstract][Full Text] [Related]
5. Effects of the 5-HT
Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
[TBL] [Abstract][Full Text] [Related]
6. Effects of mescaline and lysergic acid (d-LSD-25).
HOCH PH; CATTELL JP; PENNES HH
Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
[No Abstract] [Full Text] [Related]
7. Lysergic acid diethylamide: radioimmunoassay.
Taunton-Rigby A; Sher SE; Kelley PR
Science; 1973 Jul; 181(4095):165-6. PubMed ID: 4736456
[TBL] [Abstract][Full Text] [Related]
8. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
Bradley PB; Briggs I
Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
[TBL] [Abstract][Full Text] [Related]
9. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
SANGUINETI I; NEGRI VU; LARICCHIA R
Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
[No Abstract] [Full Text] [Related]
10. Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline.
FISCHER R
Experientia; 1955 Apr; 11(4):162-3. PubMed ID: 14380263
[No Abstract] [Full Text] [Related]
11. [Psychophysical correlations. VIII. Experimental tests in schizophrenia; lysergic acid diethylamide and mescaline].
FISCHER R; GEORGI F; WEBER R
Schweiz Med Wochenschr; 1951 Sep; 81(35):837-40. PubMed ID: 14866109
[No Abstract] [Full Text] [Related]
12. [Psychophysical correlations. VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline].
FISCHER R; GEORGI F; WEBER R
Schweiz Med Wochenschr; 1951 Aug; 81(34):817-9; contd. PubMed ID: 14866104
[No Abstract] [Full Text] [Related]
13. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
14. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
[TBL] [Abstract][Full Text] [Related]
15. Steric and electronic relationships among some hallucinogenic compounds.
Kang S; Green JP
Proc Natl Acad Sci U S A; 1970 Sep; 67(1):62-7. PubMed ID: 5272329
[TBL] [Abstract][Full Text] [Related]
16. THE HALLUCINOGENIC DRUGS.
BARRON F; JARVIK ME; BUNNELL S
Sci Am; 1964 Apr; 210():29-37. PubMed ID: 14143391
[No Abstract] [Full Text] [Related]
17. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
[TBL] [Abstract][Full Text] [Related]
18. Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy.
FREDERKING W
J Nerv Ment Dis; 1955 Mar; 121(3):262-6. PubMed ID: 14381913
[No Abstract] [Full Text] [Related]
19. Mescaline and LSD-25 in activation of temporal lobe epilepsy.
SCHWARZ BE; BICKFORD RG; MULDER DW; ROME HP
Neurology; 1956 Apr; 6(4):275-80. PubMed ID: 13309607
[No Abstract] [Full Text] [Related]
20. The inhibition of adrenergic alpha-receptors and tryptamine receptors by macusine B.
Leonard BE
J Pharm Pharmacol; 1965 Nov; 17(11):755-7. PubMed ID: 4379810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
